*0012196859
*00520240229141045.0
*007ta
*008230510s2023    no a   e m    00  0 eng
*00901770nam a2200337 c 4500
*019  $bl
*020  $a9788230855096$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999922159765402201
*035  $a(NO-DIMO)fd71575c-4c90-47f7-919c-85d78a9b04f4
*035  $a(NO-LaBS)27841501(bibid)
*035  $aoai:nb.no:pliktmonografi_000018944
*035  $aoai:nb.no:pliktmonografi_000018944
*040  $aNO-OsNB$bnob$erda
*060 4$aQZ 380
*097  $akat$9local
*1001 $aArnesen, Victoria Smith$d1994-$0(NO-TrBIB)1707990460213$4aut$_283087400
*24000$aMolecular and epigenetic biomarkers of malignant progression in immune subsets and glioblastoma$_283087500
*24510$aMolecular and epigenetic biomarkers of malignant progression in immune subsets and glioblastoma$cVictoria Smith Arnesen
*264 1$a[Bergen]$bUniversity of Bergen$c2023
*300  $a1 bind (flere pagineringer)$billustrasjoner
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Bergen, 2023
*650 2$aGlioblastoma$0(DNLM)D005909$_13272500
*650 2$aImmunotherapy$0(DNLM)D007167$_12926300
*655 7$aDoktoravhandlinger$0(uri)https://id.nb.no/vocabulary/ntsf/61$2ntsf$_202811400
*7001 $aArnesen, Victoria Smith$d1994-$0(NO-TrBIB)1707990460213$tMolecular and epigenetic biomarkers of malignant progression in immune subsets and glioblastoma$_283087400
*7102 $aUniversitetet i Bergen$bInstitutt for biomedisin$0(NO-TrBIB)10073621$4dgg$4pbl$_12926500
*85640$uhttps://urn.nb.no/URN:NBN:no-nb_pliktmonografi_000018944$3Fulltekst$yNettbiblioteket$zDigital representasjon
*913  $aNorbok$bNB
*999  $aoai:nb.bibsys.no:999920400686702202$b2023-05-13T02:17:30Z$z999920400686702202
^